These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Does cyclosporin increase lipoprotein(a) concentrations in renal transplant recipients? Webb AT; Reaveley DA; O'Donnell M; O'Connor B; Seed M; Brown EA Lancet; 1993 Jan; 341(8840):268-70. PubMed ID: 8093917 [TBL] [Abstract][Full Text] [Related]
5. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation. Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN Nephron; 1997; 75(3):277-82. PubMed ID: 9069448 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporin and serum lipids in renal transplant recipients. Kronenberg F; König P; Lhotta K; Königsrainer A; Sandholzer C; Utermann G; Dieplinger H Lancet; 1993 Mar; 341(8847):765; author reply 767. PubMed ID: 8095673 [No Abstract] [Full Text] [Related]
7. Cyclosporin and serum lipids in renal transplant recipients. Irish A Lancet; 1993 Mar; 341(8847):766; author reply 767. PubMed ID: 8095675 [No Abstract] [Full Text] [Related]
9. Evaluation of lipoprotein A in renal transplant recipients. Innocenti M; Lorenzetti M; Naldi F; Paleologo G; Pasquariello A; Marchetti P; Giannarelli R; Rindi P; Navalesi R; Rizzo G Transplant Proc; 1998 Aug; 30(5):2048. PubMed ID: 9723386 [No Abstract] [Full Text] [Related]
10. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients. Gracida C; Melchor JL; Miranda ME; Bartolano C Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191 [No Abstract] [Full Text] [Related]
11. The therapeutic window of cyclosporine in Chinese recipients of renal transplantation. Guan D; Wang R; Lu J; Wang M; Xu C Transplant Proc; 1995 Feb; 27(1):850-1. PubMed ID: 7879203 [No Abstract] [Full Text] [Related]
12. Serum lipoprotein (a) in renal transplant recipients treated with cyclosporin monotherapy compared to conventional treatment. Islam MS; Bard JM; Le Pogamp P; Leglise D; Bourbigot B; Rivalan J; Cledes J Nephrol Dial Transplant; 1994; 9(3):332-3. PubMed ID: 8052449 [No Abstract] [Full Text] [Related]
13. Cyclosporine monotherapy versus conventional therapy in the living-related renal transplant: a one center retrospective study. Masri MA; Shakuntala V; Dhawan IK; Zahir M; Shanwaz M; Hayes K; Pingle A Transplant Proc; 1993 Jun; 25(3):2248-9. PubMed ID: 8516889 [No Abstract] [Full Text] [Related]
14. Cadaveric renal transplantation: multifactorial analysis of possible causes affecting graft outcome in recipients treated with and without cyclosporine. Isa WA; Robles JE; Rosell D; Aguera LG; de Castro F; Sanchez PL; Zudaire JJ; Errasti P; Berian JM Transplant Proc; 1992 Feb; 24(1):115-7. PubMed ID: 1539200 [No Abstract] [Full Text] [Related]
15. Cyclosporin A has no impact on alterations of the lipid profile after renal transplantation. Rosman J; Evequoz D; Landmann J; Thiel G Transpl Int; 1992; 5 Suppl 1():S532-5. PubMed ID: 14621868 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of phagocytic activity of peripheral blood neutrophils in patients after kidney transplantation treated with cyclosporin and prednisone or with azathioprine with prednisone]. Hrycek A; Szołtysik I Acta Haematol Pol; 1992; 23(4):253-8. PubMed ID: 1293906 [TBL] [Abstract][Full Text] [Related]
20. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]